To receive our monthly eNews as well as event notices and other updates, just enter your email address.
Please check back in Fall 2014 for updated information.
The Mary and David Hoar Fund was established in 1975 at The New York Community Trust to promote research in the prevention and treatment of hip fractures. Administered by The New York Academy of Medicine, the Fund supports applications for clinical research as well as for developing innovative clinical programs such as those that test a novel approach to health care delivery in a cost effective and quality way. We especially encourage applications for pilot projects.
Candidates must hold an MD, PhD, or equivalent degree and are expected to conduct research in a supervised program in the greater New York area. Preferential consideration will be given junior faculty to assist in starting their careers, however, other applications will be considered provided applicants provide a clear justification. In the case of more senior faculty, it should state why an award of this type is appropriate. In the case of trainees who are not junior faculty, it should state that they would have the protected time to do the research and that they would remain at the institution for the duration of the award. Candidates must be United States citizens or permanent residents or have (at the time of application) a valid working visa that can be renewed (if required) through the period of the award.
Applicants must provide the following as part of their application:
1) Applicant's Signed Cover Letter describing previous training and experience and how the proposed activities relate to the applicant’s projected career.
2) Completed, typewritten application form signed by the applicant and authorized institutional representative from your grants or finance office.
3) Research Proposal: Include project title, applicant’s name, research site, introduction, specific aims, work done by others, work done by applicant, methods of procedure, significance, and relevant bibliography. This should not exceed four pages, including diagrams, illustrations, bibliography and any other supplemental materials. The font used should be Arial with a minimum 11 point type size.
4) Applicant's Curriculum Vitae.
5) Signed Letter of Support from your Research Sponsor detailing the applicant’s career development plan, providing a description of the research environment and available research facilities to be provided for the proposed project, and providing an analysis of the clinical and research training of the candidate.
6) Research sponsor’s NIH-format biosketch. (Sample of biosketch available at http://grants.nih.gov/grants/funding/phs398/biosketchsample.doc)
7) Signed Letter of Recommendation from the department chair or division director of the academic or medical institution located in the greater New York area where the research will take place, describing the facilities and faculty resources available for career development and explaining how the proposed research will prepare the applicant for an academic career. It should also confirm the full-time nature of the research commitment and the level of institutional support for the proposed research.
8) Documentation of mentor’s IRB or IACUC protocol approval or submission (if applicable) or waiver. The complete protocol is not required, only the appropriate approval or submission cover page. Approvals for pending protocols must be in place by the start of the grant. In the case of animal research, include a copy of the institution's current HHS Animal Welfare Assurance approval or renewal letter, or a letter from the institution's research administration office affirming that the animal facility complies with all federal standards and has been so certified.
A personal interview may be required.
Applicants have the option of proposing either a one year project with an award of $100,000 or a two year project with an award of $100,000 commencing in July of the application year. The grant is made to the awardee’s sponsoring institution for the direct support of the investigator's salary and research activities. Indirect costs and fringe benefits are not paid by this program. Grant recipients are required to submit progress and financial reports to NYAM at the mid-point and end of the grant period. Failure to comply with reporting requirements may result in termination of the grant and refund of any award monies paid, and may negatively affect consideration of future applications from the grantee’s institution. In addition, it is expected that a paper on the research project suitable for publication in a peer-reviewed journal will be submitted. For all publications acknowledgment must be made of support from The Mary and David Hoar Fellowship of The New York Community Trust and The New York Academy of Medicine
Hoar Fellowship Program
Office of Sponsored Programs
The New York Academy of Medicine
1216 Fifth Avenue
New York, New York 10029-5202
Office Hours: Wednesdays (9:00am-5:00pm)
The mission of The New York Academy of Medicine is to advance the health of people in cities. Drawing on the expertise of diverse partners worldwide and more than 2,000 elected Fellows from across the professions, our current priorities are to create environments in cities that support healthy aging; to strengthen systems that prevent disease and promote the public's health; to eliminate health disparities; and preserve and promote the heritage of medicine and public health.
Instructions on how to apply for NYAM's research fellowships, student grants, endowed lectures and awards are contained within the description of each program. Please click on your program of interest for full details.
On February 18, 2014, Amy Paller, MS, MD delivered the 60th Howard Fox, MD Memorial lecture at NYAM on the topic of “Update on Genetic Skin Disorders and Their Management.” Dr. Paller is the Walter J. Hamlin Chair and Professor of Dermatology, Professor of Pediatrics, and Principal Investigator of the NIH-funded Skin Disease Research Center at Northwestern University’s Feinberg School of Medicine. In her talk, Dr. Paller reviewed the landscape of genetic dermatological diseases and provided a front row view of cutting-edge, future treatment options through new technologies including small interfering RNA conjugated nanoparticles, stem cell therapy, and gene replacement therapy.
NYAM welcomed Michael A. Weber, MD to deliver the 2013 Nahum J. Winer Lecturer on October 8, 2013. Dr. Weber is Professor of Medicine at the SUNY Downstate College of Medicine in Brooklyn, New York. The topic of his lecture was “Unresolved Issues in Diagnosing and Treating Hypertension: Is Renal Sympathectomy An Answer?